Home › Alcohol Use Disorder (AUD) › NCT06302413
Enhancing Prospective Thinking in Early Recovery (HOME)
Enhancing Prospective Thinking in Early Recovery
Who can join
Ages 18 to 60 · All sexes
Full eligibility criteria
Inclusion Criteria: * Abstinence between ≥14 days and ≤1 year * Verbal endorsement of commitment to recovery * Outpatient * Psychotropic drugs for SUD-comorbidity * Drug/alcohol abstinence ≥ 24 hours at the time of the study day visit * English comprehension Exclusion Criteria: * Unstable medical disorders * Habitual drug use * Mu-opioid drugs * Smell/taste disorders * Unstable psychiatric conditions * Extravagant/elaborate face tattoos
About the study
The goal of this clinical trial is to use a novel virtual reality intervention to test for efficacy in reducing alcohol use and increasing abstinence, with concomitant increases in future self-identification, future time perspective, and delay-of-reward, in early recovering alcohol use disorder (AUD) persons. The main question\[s\] this trial aims to answer are:
Will the Virtual Reality (VR) intervention decrease the number of stimulant use days? Will the VR intervention produce longer abstinence periods during follow-up visits? Will the VR intervention increase alcohol abstinence rates? Will the VR intervention increase future self-identification? Will the VR intervention increase self-reported future time perspective? Will the VR intervention increase preference for delayed rewards in a laboratory delay discounting task on the study day? Will the VR intervention produce gains in the behavioral effects of future self-identification, future time perspective, and delayed rewards at the 30-day and 6-month follow-ups? Researchers will compare the experimental and control groups to see if there are differences in the results for the questions outlined above.
What is being tested
- Virtual Reality (device)
- Virtual Reality (device)
Sponsor: Indiana University · Participants: 500 · Started: Feb 15, 2024
Contact the study team
- Sarah Turo, BA · Phone: 317-963-7220
- Colton Lind, BS · Phone: 317-963-2554
Official record on ClinicalTrials.gov — NCT06302413
Locations in the U.S.
| Indiana | Indiana University School of Medicine - Goodman Hal, Indianapolis |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.